Inhibitors of Bruton's Tyrosine Kinase
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 39 of these applications claim priority to application 60/826,720, filed Sep 22, 2006. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 7,514,444 | Inhibitors of Bruton's Tyrosine Kinase In force · Medium confidence | Pharmacyclics LLC | In force | Medium confidence | ||
| US 7,960,396 | Inhibitors of Bruton's Tyrosine Kinase In force · Medium confidence | Pharmacyclics LLC | In force | Medium confidence | ||
| US 8,158,786 | Inhibitors of Bruton's Tyrosine Kinase In force · Medium confidence | Pharmacyclics LLC | In force | Medium confidence | ||
| US 8,232,280 | Inhibitors of Bruton's Tyrosine Kinase In force · Low confidence | Pharmacyclics LLC | In force | Low confidence | ||
| US 8,236,812 | Inhibitors of Bruton's Tyrosine Kinase In force · High confidence | Pharmacyclics LLC | In force | High confidence | ||
| US 8,399,470 | Inhibitors of Bruton's Tyrosine Kinase In force · Low confidence | Pharmacyclics LLC | In force | Low confidence | ||
| US 8,476,284 | Inhibitors of Bruton's Tyrosine Kinase In force · Low confidence | Pharmacyclics LLC | In force | Low confidence | ||
| US 8,497,277 | Inhibitors of Bruton's Tyrosine Kinase In force · Low confidence | Pharmacyclics LLC | In force | Low confidence | ||
| US 8,501,751 | Inhibitors of Bruton's Tyrosine Kinase In force · Medium confidence | Pharmacyclics LLC | In force | Medium confidence | ||
| US 8,552,010 | Inhibitors of Bruton's Tyrosine Kinase In force · High confidence | Pharmacyclics LLC | In force | High confidence | ||
| 58 more patents in this group · Pro | ||||||
10 of 68 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 68, including 44 expiring within the 18 months from Nov 15, 2026.
45 of these are in force and held by Pharmacyclics, Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.